Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Metabolic studies appear to place him in a subgroup of atypical galactosemic patients as described by Segal et al.
This child had never exhibited any symptoms of galactosemia although he lacked galactose-1-phosphate uridyl transferase activity in his circulating red cells.
This fibroblast cell line was established by W.J. Mellman from a skin biopsy of an 8-year-old Black male with asymptomatic galactosemia.
His younger sibling, (M.W.) demonstrated the classic galactosemic picture in infancy [Cell line CHP3, ATCC CCL-132